Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) FCF Margin (2020 - 2025)

Historic FCF Margin for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to 81.39%.

  • Strata Critical Medical's FCF Margin fell 732100.0% to 81.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.49%, marking a year-over-year increase of 4400.0%. This contributed to the annual value of 13.43% for FY2024, which is 18700.0% up from last year.
  • Latest data reveals that Strata Critical Medical reported FCF Margin of 81.39% as of Q3 2025, which was down 732100.0% from 7.57% recorded in Q2 2025.
  • Strata Critical Medical's FCF Margin's 5-year high stood at 1.86% during Q3 2023, with a 5-year trough of 81.39% in Q3 2025.
  • For the 5-year period, Strata Critical Medical's FCF Margin averaged around 29.73%, with its median value being 21.79% (2022).
  • Per our database at Business Quant, Strata Critical Medical's FCF Margin surged by 479300bps in 2023 and then plummeted by -732100bps in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's FCF Margin stood at 25.35% in 2021, then increased by 6bps to 23.9% in 2022, then rose by 18bps to 19.68% in 2023, then surged by 77bps to 4.59% in 2024, then tumbled by -1675bps to 81.39% in 2025.
  • Its FCF Margin was 81.39% in Q3 2025, compared to 7.57% in Q2 2025 and 5.28% in Q1 2025.